Skip to main content
Zur Rose Group AG logo

Zur Rose Group AG — Investor Relations & Filings

Ticker · ROSE ISIN · CH0042615283 LEI · 50670038OH136R5Z4663 SW Wholesale and retail trade
Filings indexed 477 across all filing types
Latest filing 2021-08-18 Investor Presentation
Country CH Switzerland
Listing SW ROSE

DocMorris AG, formerly Zur Rose Group AG, is a leading European e-commerce pharmacy. The company provides an online platform for medicines and develops digital health services. Its core strategy involves creating a comprehensive digital health ecosystem that connects patients, doctors, pharmacies, and health insurers on a single platform. The company's vision is to enable individuals to manage their health with a single click, offering integrated care and treatment solutions. Originally founded as a pharmacy wholesaler, it has evolved to focus on the digitalization of healthcare services.

Recent filings

Filing Released Lang Actions
Presentation on half-year results 2021
Investor Presentation Classification · 95% confidence The document is a presentation titled 'H1 2021 in review' for the Zur Rose Group. It contains detailed financial performance metrics, balance sheet data, operational highlights, and strategic outlooks for the first half of 2021. It is structured as a slide deck for investors, providing a comprehensive overview of the company's financial and operational status for the period. It is not a full annual report (10-K) nor a simple announcement (RPA), but rather a detailed investor-focused presentation. H1 2021
2021-08-18 English
Präsentation zum Halbjahresergebnis 2021
Investor Presentation Classification · 95% confidence The document is a presentation titled 'H1 2021 in review' for the Zur Rose Group. It contains financial highlights, performance metrics, balance sheet data, and strategic outlooks for the first half of the fiscal year. It is structured as a slide deck or investor presentation rather than a formal quarterly report or earnings release, as it focuses on visual summaries, bullet points, and strategic roadmap updates. Therefore, it is classified as an Investor Presentation. H1 2021
2021-08-18 German
Half-Year Report 2021
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Half-Year Report 2021' and contains comprehensive financial statements, including a Consolidated Income Statement, Balance Sheet, and Cash Flow Statement for the period ending June 30, 2021. It provides detailed management commentary on business performance, strategy, and market outlook. As it is a substantive financial report for a period shorter than a full fiscal year, it fits the definition of an Interim/Quarterly Report. H2 2021
2021-08-18 English
Halbjahresbericht 2021
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Halbjahresbericht 2021' (Half-Year Report 2021) and contains comprehensive financial statements, including the consolidated income statement, balance sheet, and cash flow statement for the period ending June 30, 2021. It also includes a letter to shareholders and management commentary on business performance. This fits the definition of an Interim/Quarterly Report (IR) as it provides substantive financial data and analysis for a period shorter than a full fiscal year. H2 2021
2021-08-18 German
Zur Rose Group strengthens Group Management: Madhu Nutakki to become Chief Technology Officer
Board/Management Information Classification · 100% confidence The document is a press release dated June 15, 2021, announcing a significant personnel change: the appointment of Madhu Nutakki as the new Chief Technology Officer (CTO) of the Zur Rose Group. This announcement details the executive's background, responsibilities, and quotes from the CEO regarding the strategic importance of the role. This content directly aligns with the definition of 'Board/Management Information' (MANG), which covers announcements of changes in senior management.
2021-06-15 English
Annual General Meeting of Zur Rose Group AG: Shareholders approve all proposals
AGM Information Classification · 98% confidence The document explicitly discusses the 'Annual General Meeting of Zur Rose Group AG' and details the outcomes, including shareholder approvals for reports, director re-elections, and capital structure amendments. The key phrase is 'Annual General Meeting' and the content focuses on the results and resolutions passed during that meeting. This aligns directly with the definition for AGM Information (AGM-R). Although it mentions approving the Annual Financial Statements, the primary context is the meeting itself, not the filing of the full 10-K or AR.
2021-04-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.